It has earlier been described that anti-Ro52 is associated with poor outcome in ASS-related ILD [39, 40], and Marie et al. [41] have also reported anti-Ro52 as a prognostic factor for the muscle component in the syndrome. The gene discussed is TRIM21; the disease is interstitial lung disease.